ArticleFrontiers in ophthalmology2026
Case Report: Marked bilateral optic disc edema as the presenting manifestation of thyroid eye disease with dysthyroid optic neuropathy.
Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The aim of this study was to report an atypical presentation of dysthyroid optic neuropathy (DON) characterized by severe bilateral optic disc edema mimicking papilledema. Methods: A 71-year-old man with hypothyroidism presented with 6 months of progressive bilateral vision loss and Frisén grade 4-5 optic disc edema. Comprehensive neuro-ophthalmic evaluation, orbital imaging, and laboratory testing were performed to establish the diagnosis. Results: Despite presenting with severe optic disc edema typically associated with papilledema, imaging revealed Type 2 thyroid eye disease with apical muscular crowding exceeding 67% and elevated thyroid-stimulating immunoglobulin. Normal lumbar puncture opening pressure excluded elevated intracranial pressure. Following treatment with high-dose intravenous methylprednisolone and staged bilateral three-wall orbital decompression, visual acuity improved from 20/30 to 20/20 bilaterally, with complete resolution of disc edema and visual field defects at 3 months follow-up. Conclusions: Severe optic disc edema is an uncommon but important presenting feature of DON that may mimic papilledema. This case emphasizes the critical importance of considering thyroid eye disease in the differential diagnosis of bilateral optic disc edema, even in the absence of prominent orbital signs, and demonstrates excellent visual outcomes with prompt corticosteroid therapy and surgical decompression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.